Gene · 868
Papers1,946
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,946
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unraveling the Dual Role of circ-CBLB and ETS-1 in Rheumatoid Arthritis: Biomarkers and Therapeutic Targets. | Int J Rheum Dis | 2025 | 40095292 | PubTator, text mining | PubMed |
| Germline mutation in Cbl proto-oncogene B is associated with inherited thrombocytopenia and predisposes megakaryocytes to ferroptosis. | Biochim Biophys Acta Mol Basis Dis | 2025 | 40044065 | PubTator, text mining | PubMed |
| Polymersome-mediated Cbl-b silencing activates T cells against solid tumors. | Biomater Sci | 2025 | 40017436 | PubTator, text mining | PubMed |
| Novel 6-Substituted-3-Phenylisoindolin-1-ones as Cbl-B Inhibitors for Treating Cancer. | ACS Med Chem Lett | 2025 | 39967644 | PubTator, text mining | PubMed |
| Phenotype puzzle: the role of novel LMBRD1 gene variant in Cbl deficiency causing Dyskeratosis Congenita-like clinical manifestations. | J Hum Genet | 2025 | 39939801 | PubTator, text mining | PubMed |
| Cbl-b inhibition improves manufacturing efficiency and antitumoral efficacy of anti-CD19 CAR-T cells. | Int Immunopharmacol | 2025 | 39752754 | PubTator, text mining | PubMed |
| CBL-B - An upcoming immune-oncology target. | Expert Opin Ther Pat | 2025 | 39582379 | PubTator, text mining | PubMed |
| Gene expression analysis of Schizophrenia. | Bioinformation | 2024 | 40162448 | PubTator, text mining | PubMed |
| The miR-23a/27a/24 - 2 cluster drives immune evasion and resistance to PD-1/PD-L1 blockade in non-small cell lung cancer. | Mol Cancer | 2024 | 39736629 | PubTator, text mining | PubMed |
| Potential Therapeutic Benefit of the Selective Inhibitors of Casitas B Cell Lymphoma-b (CBL-B) in Cancer Immunotherapy. | ACS Med Chem Lett | 2024 | 39691533 | PubTator, text mining | PubMed |
| Inhibition of Cbl-b restores effector functions of human intratumoral NK cells. | J Immunother Cancer | 2024 | 39551607 | PubTator, text mining | PubMed |
| [Serum from Xinfeng Capsule-treated rats affect the proliferation and apoptosis of fibroblast-like synoviocytes in rheumatoid arthritis by regulating circular RNA Cbl proto-oncogene B (circ-CBLB)]. | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | 2024 | 39442967 | PubTator, text mining | PubMed |
| CD73 promotes non-small cell lung cancer metastasis by regulating Axl signaling independent of GAS6. | Proc Natl Acad Sci U S A | 2024 | 39423241 | PubTator, text mining | PubMed |
| CBL-b E3 ligase-mediated neddylation and activation of PARP-1 induce vascular calcification. | Exp Mol Med | 2024 | 39349831 | PubTator, text mining | PubMed |
| Presence of vitamin B12 metabolism in the last common ancestor of land plants. | Philos Trans R Soc Lond B Biol Sci | 2024 | 39343018 | PubTator, text mining | PubMed |
| Cbl-b inhibition promotes less differentiated phenotypes of T cells with enhanced cytokine production. | Cell Immunol | 2024 | 39186873 | PubTator, text mining | PubMed |
| Accelerated Discovery of Carbamate Cbl-b Inhibitors Using Generative AI Models and Structure-Based Drug Design. | J Med Chem | 2024 | 39132828 | PubTator, text mining | PubMed |
| The role of CBL family ubiquitin ligases in cancer progression and therapeutic strategies. | Front Pharmacol | 2024 | 39130630 | PubTator, text mining | PubMed |
| Oncoprotein-induced transcript 3 protein-enriched extracellular vesicles promotes NLRP3 ubiquitination to alleviate acute lung injury after cardiac surgery. | J Mol Cell Cardiol | 2024 | 39089571 | PubTator, text mining | PubMed |
| PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets. | EMBO Mol Med | 2024 | 39030301 | Swiss-Prot, curated | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/868/papers?page=4